15 April 2026 : Clinical Research
Phospho-Histone H3 as a Tool for Improved Mitotic Counting and Risk Assessment in Gastrointestinal Stromal Tumors: A Study of 241 Cases
Xu LiuDOI: 10.12659/MSM.952182
Med Sci Monit 2026; 32:e952182
Table 4 Pairwise inter-observer variability results of mitotic counts using HE and PHH3.
| Characteristic | Correlation | 95% CI | P value |
|---|---|---|---|
| HE | |||
| Intra-class | 0.648 | 0.534–0.748 | |
| Observer 1/Observer 2 | 0.677 | 0.524–0.787 | <0.01 |
| Observer 1/Observer 3 | 0.463 | 0.254–0.631 | <0.01 |
| Observer 2/Observer 3 | 0.623 | 0.453–0.749 | <0.01 |
| PHH3 | |||
| Intra-class | 0.710 | 0.608–0.795 | |
| Observer 1/Observer 2 | 0.804 | 0.702–0.875 | <0.01 |
| Observer 1/Observer 3 | 0.639 | 0.474–0.761 | <0.01 |
| Observer 2/Observer 3 | 0.648 | 0.486–0.767 | <0.01 |
| HE – hematoxylin-eosin; PHH3 – phospho-histone H3; CI – confidence interval. | |||






